Springworks Therapeutics, on Breakout alert $swtx

NASDAQ:SWTX   SpringWorks Therapeutics, Inc
Massive breakout potential setting up.
Short interest 7%
Springworks Therapeutics , Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT .

Do you want to GAIN an Edge on Wall Street? 🤑💰📈

1) Sign Up for Free @

2) Follow our Telegram Channel @

3) Join our LIVE CHAT on our Discord @